Pediatric Neurology News

Many children and adolescents with COVID-19 or multisystem inflammatory syndrome experienced neurologic involvement, with largely transient symptoms, according to a case series of almost 1,700 patients published in JAMA Neurology.

The NIH is recognizing Rare Disease Day today with virtual panel discussions and other digital programs to raise awareness about the array of rare conditions that affect approximately 30 million Americans, according to its website.

The FDA approved fosdenopterin injection, a first-in-class treatment to reduce risk for death due to molybdenum cofactor deficiency type A, a rare, genetic, metabolic disorder that typically presents in the first few days of life.

The FDA announced that it has granted accelerated approval for Amondys 45 injections as a treatment for a rare form of Duchenne muscular dystrophy, according to a press release.

Spending more time in sunlight was associated with a significantly reduced risk for pediatric-onset MS, according to findings presented at the ACTRIMS virtual meeting.

The FDA granted 510(k) clearance to electroCore to expand the approval of gammaCore, the company’s non-invasive vagus nerve stimulation, for the acute and preventative treatment of adolescent migraine, according to a press release.

Children with epilepsy experienced more sleep-related problems such as night waking, parasomnias and sleep-disordered breathing than children without epilepsy, according to a meta-analysis published in Sleep Medicine Reviews.

A neonatal seizures task force established by the International League Against Epilepsy, or ILAE, published a new classification and framework for neonatal seizures that aligns with the ILAE’s 2017 classification of seizures and epilepsies.

Nearly half of adolescent drivers returned to driving fewer than 2 weeks after a concussion on average, according to a study published in the Journal of Adolescent Health.

Findings published last month in Annals of Neurology demonstrated that preventive use of vigabatrin, an antiepileptic drug, positively altered the natural history of seizures in infants with tuberous sclerosis complex.